LogicBio Therapeutics, Inc. EBITDA Margin 2018-2022 | LOGC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for LogicBio Therapeutics, Inc. (LOGC) over the last 10 years. The current EBITDA margin for LogicBio Therapeutics, Inc. as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.01B | $-0.03B | -236.36% |
| 2022-06-30 | $0.01B | $-0.03B | -300.00% |
| 2022-03-31 | $0.01B | $-0.04B | -437.50% |
| 2021-12-31 | $0.01B | $-0.04B | -780.00% |
| 2021-09-30 | $0.00B | $-0.04B | -900.00% |
| 2021-06-30 | $0.00B | $-0.03B | -1133.33% |
| 2021-03-31 | $0.00B | $-0.03B | -1066.67% |
| 2020-12-31 | $0.00B | $-0.03B | -775.00% |
